Guided Therapeutics, Inc. Receives May 8th Meeting Date From FDA To Discuss LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that the company has been given a face-to-face meeting date of May 8, 2014, by the U.S. Food and Drug Administration (FDA), to discuss the company’s response to the September 6, 2013 not-approvable letter that the company received from the agency.

Help employers find you! Check out all the jobs and post your resume.